Your browser doesn't support javascript.
loading
Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.
Chea, Nora; Eure, Taniece; Alkis Ramirez, Rebecca; Zlotorzynska, Maria; Blazek, Gregory T; Nadle, Joelle; Lee, Jane; Czaja, Christopher A; Johnston, Helen; Barter, Devra; Kellogg, Melissa; Emanuel, Catherine; Meek, James; Brackney, Monica; Carswell, Stacy; Thomas, Stepy; Fridkin, Scott K; Wilson, Lucy E; Perlmutter, Rebecca; Marceaux-Galli, Kaytlynn; Fell, Ashley; Lovett, Sara; Lim, Sarah; Lynfield, Ruth; Shrum Davis, Sarah; Phipps, Erin C; Sievers, Marla; Dumyati, Ghinwa; Myers, Christopher; Hurley, Christine; Licherdell, Erin; Pierce, Rebecca; Ocampo, Valerie L S; Hall, Eric W; Wilson, Christopher; Adre, Cullen; Kirtz, Erika; Markus, Tiffanie M; Billings, Kathryn; Plumb, Ian D; Abedi, Glen R; James-Gist, Jade; Magill, Shelley S; Grigg, Cheri T.
Afiliação
  • Chea N; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Eure T; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Alkis Ramirez R; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Zlotorzynska M; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Blazek GT; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Nadle J; Chenega Enterprise Systems and Solutions, LLC, Chesapeake, VA, USA.
  • Lee J; California Emerging Infections Program, Oakland, CA, USA.
  • Czaja CA; California Emerging Infections Program, Oakland, CA, USA.
  • Johnston H; Colorado Department of Public Health and Environment, Denver, CO, USA.
  • Barter D; Colorado Department of Public Health and Environment, Denver, CO, USA.
  • Kellogg M; Colorado Department of Public Health and Environment, Denver, CO, USA.
  • Emanuel C; Colorado Department of Public Health and Environment, Denver, CO, USA.
  • Meek J; Colorado Department of Public Health and Environment, Denver, CO, USA.
  • Brackney M; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA.
  • Carswell S; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA.
  • Thomas S; Georgia Emerging Infections Program, Atlanta Veterans Affairs Medical Center, Foundation for Atlanta Veterans Education and Research, Atlanta, GA, USA.
  • Fridkin SK; Georgia Emerging Infections Program, Atlanta Veterans Affairs Medical Center, Foundation for Atlanta Veterans Education and Research, Atlanta, GA, USA.
  • Wilson LE; Georgia Emerging Infections Program, Emory University School of Medicine, Atlanta, GA, USA.
  • Perlmutter R; Maryland Department of Health, Baltimore, MD, USA.
  • Marceaux-Galli K; Maryland Department of Health, Baltimore, MD, USA.
  • Fell A; Maryland Department of Health, Baltimore, MD, USA.
  • Lovett S; Minnesota Department of Health, St. Paul, MN, USA.
  • Lim S; Minnesota Department of Health, St. Paul, MN, USA.
  • Lynfield R; Minnesota Department of Health, St. Paul, MN, USA.
  • Shrum Davis S; Minnesota Department of Health, St. Paul, MN, USA.
  • Phipps EC; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, NM, USA.
  • Sievers M; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, NM, USA.
  • Dumyati G; New Mexico Department of Health, Santa Fe, NM, USA.
  • Myers C; New Mexico Department of Health, Santa Fe, NM, USA.
  • Hurley C; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA.
  • Licherdell E; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA.
  • Pierce R; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA.
  • Ocampo VLS; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA.
  • Hall EW; Public Health Division, Oregon Health Authority, Portland, OR, USA.
  • Wilson C; Public Health Division, Oregon Health Authority, Portland, OR, USA.
  • Adre C; Oregon Health and Science University and Portland State University School of Public Health, Oregon Health and Science University, Portland, OR, USA.
  • Kirtz E; Tennessee Department of Health, Nashville, TN, USA.
  • Markus TM; Tennessee Department of Health, Nashville, TN, USA.
  • Billings K; Tennessee Department of Health, Nashville, TN, USA.
  • Plumb ID; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Abedi GR; Vanderbilt University Medical Center, Nashville, TN, USA.
  • James-Gist J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Magill SS; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Grigg CT; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Infect Control Hosp Epidemiol ; : 1-9, 2024 May 21.
Article em En | MEDLINE | ID: mdl-38770586
ABSTRACT

BACKGROUND:

Understanding characteristics of healthcare personnel (HCP) with SARS-CoV-2 infection supports the development and prioritization of interventions to protect this important workforce. We report detailed characteristics of HCP who tested positive for SARS-CoV-2 from April 20, 2020 through December 31, 2021.

METHODS:

CDC collaborated with Emerging Infections Program sites in 10 states to interview HCP with SARS-CoV-2 infection (case-HCP) about their demographics, underlying medical conditions, healthcare roles, exposures, personal protective equipment (PPE) use, and COVID-19 vaccination status. We grouped case-HCP by healthcare role. To describe residential social vulnerability, we merged geocoded HCP residential addresses with CDC/ATSDR Social Vulnerability Index (SVI) values at the census tract level. We defined highest and lowest SVI quartiles as high and low social vulnerability, respectively.

RESULTS:

Our analysis included 7,531 case-HCP. Most case-HCP with roles as certified nursing assistant (CNA) (444, 61.3%), medical assistant (252, 65.3%), or home healthcare worker (HHW) (225, 59.5%) reported their race and ethnicity as either non-Hispanic Black or Hispanic. More than one third of HHWs (166, 45.2%), CNAs (283, 41.7%), and medical assistants (138, 37.9%) reported a residential address in the high social vulnerability category. The proportion of case-HCP who reported using recommended PPE at all times when caring for patients with COVID-19 was lowest among HHWs compared with other roles.

CONCLUSIONS:

To mitigate SARS-CoV-2 infection risk in healthcare settings, infection prevention, and control interventions should be specific to HCP roles and educational backgrounds. Additional interventions are needed to address high social vulnerability among HHWs, CNAs, and medical assistants.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos